Investors

2016 News

Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle 
11/29/16Forward Pharma Reports Third Quarter 2016 Financial and Operational Results
COPENHAGEN, Denmark, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the third quarter ended September 30, 2016.  Net loss for the third quarter ended September 30, 2016 was $11.0 million, or $0.23 per basic share versus a net loss of $15.8 million, or $0.34 per basic share for the third quarter of 2015.  On a non-GAAP basis, after removing the effect of non-cash income and expense items, our third qua... 
Printer Friendly Version
11/02/16Forward Pharma CFO to Participate in the Credit Suisse Annual Healthcare Conference in November
COPENHAGEN, Denmark, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conference:    Credit Suisse Annual Healthcare Conference to be held at The Phoenician in Scottsdale, Arizona.  Mr. Sendek ... 
Printer Friendly Version
09/06/16Forward Pharma CFO to Participate in Three Investor Conferences in September
COPENHAGEN, Denmark, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conferences: Wells Fargo Securities Healthcare Conference to be held at the Westin Boston Waterfront in Boston, Mas... 
Printer Friendly Version
09/01/16Forward Pharma Reports Second Quarter 2016 Financial and Operational Results
COPENHAGEN, Denmark, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the second quarter ended June 30, 2016.  Net loss for the second quarter ended June 30, 2016 was $15.1 million, or $0.32 per basic share versus a net loss of $17.7 million, or $0.38 per basic share for second quarter of 2015.  On a non-GAAP basis, after removing the effect of non-cash income and expense items, our second quarter net ... 
Printer Friendly Version
06/06/16Forward Pharma CFO to Participate in Two Investor Conferences in June
COPENHAGEN, Denmark, June 06, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conferences: Jefferies Healthcare Conference to be held at the Grand Hyatt in New York, New York.  Mr. Sendek will p... 
Printer Friendly Version
06/02/16Forward Pharma Reports First Quarter 2016 Financial and Operational Results
COPENHAGEN, Denmark, June 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the first quarter ended March 31, 2016.  Net loss for the first quarter ended March 31, 2016 was $16.9 million, or $(0.36) per basic share versus net income of $6.0 million, or $0.13 per basic share for first quarter of 2015.  On a non-GAAP basis, after removing the effect of non-cash income and expense items, our first quarter net lo... 
Printer Friendly Version
05/09/16Forward Pharma Announces Board of Directors Expansion with Appointment of Two New Non-Executive Directors
COPENHAGEN, Denmark, May 09, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Karen Smith and Dr. Duncan Moore have been appointed to its Board of Directors as non-executive directors, expanding the Board to seven members.  Dr. Moore will also serve as a member of the Audit Committee.  The elections took place on May 6, 2016 at the Company's Annual General Meeting in Copenhagen. “I am very pleased that Forward Pharma has been able to continue... 
Printer Friendly Version
05/02/16Forward Pharma CFO to Present at the Deutsche Bank Health Care Conference
COPENHAGEN, Denmark, May 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conference:     Deutsche Bank Annual Health Care Conference to be held at the InterContinental Hotel in Boston, Massa... 
Printer Friendly Version
04/12/16Forward Pharma Reports Fourth Quarter and Year End 2015 Financial and Operational Results
COPENHAGEN, Denmark, April 12, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the fourth quarter and year ended December 31, 2015. Net loss for the fourth quarter and year ended December 31, 2015 was $9.6 million and $37.0 million, respectively. Loss per share for the fourth quarter and year ended December 31, 2015 was $0.20 and $0.79, respectively.  On a non-GAAP basis, after removing the effect of non-cash i... 
Printer Friendly Version
02/09/16Forward Pharma CFO to Participate in Two Investor Conferences in February
COPENHAGEN, Denmark, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conferences: Leerink Partners 5th Annual Global Healthcare Conference to be held at the Waldorf Astoria in New York, New York.... 
Printer Friendly Version